Metoprolol Succinate/Empagliflozin/Spironolactone
- Generic Name
- Metoprolol Succinate/Empagliflozin/Spironolactone
Polypill for Prevention of Cardiomyopathy
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT06143566
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Polypill in Acute Coronary Syndrome
- Conditions
- Lipid DisorderCoronary Artery DiseaseAcute Coronary Syndrome
- Interventions
- Drug: Usual Care (individual medications prescribed by primary cardiologist)
- First Posted Date
- 2022-08-25
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT05514938
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Polypill Strategy for Heart Failure With Reduced Ejection Fraction
- First Posted Date
- 2020-11-17
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 175
- Registration Number
- NCT04633005
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
A Polypill for Secondary Prevention of Ischemic Heart Disease
- Conditions
- Non-ST Elevation Myocardial InfarctionAcute Myocardial InfarctionST Elevation Myocardial Infarction
- Interventions
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 1200
- Registration Number
- NCT03541109
- Locations
- 🇮🇷
Chamran cardiology hospital, Isfahan, Iran, Islamic Republic of
🇮🇷Cardiovascular Research Institute, Isfahan, Iran, Islamic Republic of
Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants
- First Posted Date
- 2018-03-09
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 4415
- Registration Number
- NCT03459560
- Locations
- 🇮🇷
Pars Cohort Center, Shiraz, Fars, Iran, Islamic Republic of
Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill
- First Posted Date
- 2011-01-07
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 8410
- Registration Number
- NCT01271985
- Locations
- 🇮🇷
Golestan Cohort Study Center, Gonbad, Golestan, Iran, Islamic Republic of
Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
- First Posted Date
- 2010-11-22
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 2400
- Registration Number
- NCT01245608
- Locations
- 🇮🇷
Golestan Cohort Center, Gonbad, Golestan, Iran, Islamic Republic of
UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events
- Conditions
- Cardiovascular Diseases
- Interventions
- Drug: Usual cardiovascular medications
- First Posted Date
- 2010-01-27
- Last Posted Date
- 2012-11-27
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 2004
- Registration Number
- NCT01057537
- Locations
- 🇮🇳
George Institute for International Health - India, Hyderabad, India
🇮🇳Public Health Foundation of India, New Dehli, India
🇮🇪Royal College of Surgeons in Ireland Research Institute, Dublin, Ireland
Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
- Conditions
- Cardiovascular DiseaseHypertensionHyperlipidemiaHeart Disease
- Interventions
- Drug: Placebo drug
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2009-10-02
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 475
- Registration Number
- NCT00603590
- Locations
- 🇮🇷
Kalaleh Heart Study Center, Kalaleh, Golestan, Iran, Islamic Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.